Production (Stage)
CG Oncology, Inc.
CGON
$25.46
-$0.40-1.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.22% | 37.23% | -2.20% | -2.41% | 201.86% |
| Total Receivables | -55.83% | 470.07% | -24.73% | 18.95% | 66.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.59% | 1.76% | 3.99% | -9.60% | 87.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.03% | 36.61% | -2.09% | -2.55% | 198.06% |
|
|
|||||
| Total Current Assets | -7.03% | 36.61% | -2.09% | -2.55% | 198.06% |
| Net Property, Plant & Equipment | 163.08% | 45.86% | -18.16% | -7.19% | -9.37% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 27,231.91% | 77.36% | 0.00% | 0.00% | -98.87% |
| Total Assets | -3.53% | 36.62% | -2.10% | -2.55% | 190.57% |
|
|
|||||
| Total Accounts Payable | 3.28% | 59.89% | -9.24% | -3.59% | 43.68% |
| Total Accrued Expenses | 6.65% | 28.10% | 58.82% | 44.98% | -50.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.10% | -17.33% | -5.06% | 7.73% | 1.38% |
| Total Finance Division Other Current Liabilities | 10.32% | 97.29% | 68.70% | -53.55% | -74.73% |
| Total Other Current Liabilities | 10.32% | 97.29% | 68.70% | -53.55% | -74.73% |
| Total Current Liabilities | 5.96% | 36.71% | 31.87% | 18.72% | -29.96% |
|
|
|||||
| Total Current Liabilities | 5.96% | 36.71% | 31.87% | 18.72% | -29.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1,401.92% | -26.76% | -39.83% | -35.87% | -24.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.35% | 36.42% | 31.16% | 17.73% | -29.93% |
|
|
|||||
| Common Stock & APIC | 0.61% | 31.59% | 0.67% | 0.32% | 10,362.06% |
| Retained Earnings | -15.81% | -17.08% | -12.31% | -12.87% | -13.03% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.90% | 36.63% | -2.82% | -2.91% | 562.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.90% | 36.63% | -2.82% | -2.91% | 562.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.90% | 36.63% | -2.82% | -2.91% | 207.88% |
|
|
|||||